Press release

Evonik to become a partner in HP Inc.’s Open Platform program for new 3D printing materials

July 13, 2016

Evonik Industries is driving forward its commitment to the attractive 3D printing market: The specialty chemicals company will participate in HP Inc.’s Open Platform program and introduce new customized powder materials to the market for HP Multi Jet Fusion™ technology.

As a result of active participation in HP’s Open Materials program, Evonik expects to see further development in additive manufacturing technologies in the direction of large-scale production of components, such as those used in the automotive and aircraft industries. Therefore, the Group intends to launch special powder materials for this innovative 3D printing technology in HP’s Open Platform program.

“HP’s Multi Jet Fusion™ technology opens up new 3D printing applications and, in doing so, creates the basis for researching new materials for the future,” says Dr. Matthias Kottenhahn, head of Evonik’s High Performance Polymers Business Line.

Years of experience in the development of polyamide powders

Evonik has been developing special polymer materials that enable the industrial manufacture of high-tech components in 3D printing for many years. The polyamide 12-based powders from the VESTOSINT® brand enable outstanding processing quality and are designed to suit the 3D printing technology profile of properties perfectly.

VESTOSINT® is a modified polyamide-based powder that is produced at Evonik’s Marl site in Germany using the company’s own special process. The Group is currently expanding its existing annual capacity for VESTOSINT® in order to meet amongst other things the rising demand for 3D printing. The new production line is scheduled to start operations at the end of 2017.

Contact

Scarlett Shi

Contact

  • Company information

    Evonik, the creative industrial group from Germany, is one of the world leaders
    in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.

  • Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late 1970’s; with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavor to grow our business in the region. The company now has around 3,000 employees in the Greater China region, the regional sales reached over €1.3 billion in 2015.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.